kristina.kirschner@glasgow.ac.uk (K.K.), nicola_neretti@brown.edu (N.N.), tamir.chandra@igmm.ed.ac.uk (T.C.) In Brief Teo et al. found that secondary senescence in vitro and in vivo requires Notch, rather than SASP alone, as previously thought. The authors show that primary and secondary senescence are distinct molecular endpoints. A blunted secretory phenotype and the induction of fibrillar collagens in secondary senescence point toward functional diversification.
INTRODUCTION
Cellular senescence is a stress response, resulting in stable cell cycle arrest, tumor suppression, aging, and wound healing (Adams, 2009; Campisi, 2013; Jun and Lau, 2010; van Deursen, 2014) . Aberrant activation of the Ras oncogene triggers oncogene-induced senescence (OIS), conferring a precancerous state (Di Micco et al., 2006; Serrano et al., 1997) . OIS is an in vivo tumor suppressor mechanism (Braig et al., 2005; Xue et al., 2007) with the p53 and Rb/p16 pathways as major mediators of senescence induction and maintenance (Kirschner et al., 2015; Serrano et al., 1997) . OIS is characterized by multiple phenotypical changes, such as heterochromatic foci (Adams, 2007; Chandra and Kirschner, 2016; Criscione et al., 2016; Kirschner et al., 2015; Narita et al., 2003) and the senescenceassociated secretory phenotype (SASP) (Acosta et al., 2008; Coppé et al., 2008; Kuilman et al., 2008) . Through the secretion of extracellular matrix proteases, interleukins, and chemokines, OIS cells recruit immune cells, mediating their own clearance. SASP has been implicated in cancer initiation (Watanabe et al., 2017) by creating an inflammatory pro-tumorigenic microenvironment. SASP factors play a role in cellular reprogramming (Mosteiro et al., 2016; Ritschka et al., 2017 ) and contribute to aging and tissue degeneration (Osorio et al., 2012; Soria-Valles et al., 2019) . SASP acts in a paracrine fashion to induce secondary senescence in surrounding cells (Acosta et al., 2013) . Paracrine secondary senescence is thought to enhance immune surveillance and to act as a failsafe mechanism minimizing chances of retaining damaged cells (Acosta et al., 2013; Kuilman et al., 2008; Nelson et al., 2012) . Recently, ectopic Notch pathway activation has been implicated as an intermediate phenomenon during primary senescence induction, resulting in a distinct secretome (Hoare et al., 2016) . The role of Notch in secondary OIS mediation remains undescribed.
Here, we use single-cell RNA sequencing (scRNA-seq) to decipher the heterogeneity within OIS populations. Our singlecell experiments reveal two distinct transcriptional endpoints in primary senescence, separated by their activation of Notch, with secondary senescent cells uniformly progressing to an endpoint characterized by Notch activation in vivo and in vitro. We confirm Notch-mediated senescence as an essential mediator of secondary, juxtacrine senescence in OIS.
Primary and Secondary Senescence Have Distinct Transcriptomes
To investigate dynamic changes and cell-cell heterogeneity in OIS, we performed a scRNA-seq time course experiment before and after 2, 4, and 7 days of RasV12 induction, using H-RasG12V-induced IMR90 (ER:IMR90) fibroblasts (Young et al., 2009 ) and the Smart-Seq2 protocol (Picelli et al., 2014) ( Figure 1A ). After stringent filtering ( Figure 1B ; Figures S1A-S1D; Table S1 ), we obtained a final cell count of 100/288 for day 0, 41/96 for day 2, 42/96 for day 4, and 41/288 for day 7 for downstream analysis ( Figure S1D ). To confirm a senescence phenotype at day 7, we profiled bromodeoxyuridine (BrdU) incorporation (37/390 cells [9%]), senescence associated heterochromatic focis (SAHF; 265/390 cells [68%]), and senescence-associated beta-galactosidase (SA-Beta Gal) (428/523 cells [82%]) ( Figure S1E ). To assess time-dependent changes in the transcriptome, we ordered cells along a pseudo-temporal trajectory based on differential gene expression between growing and senescence (adjusted p < 0.05; Table S2 ( Figure 1C ) (Kharchenko et al., 2014) . Using Monocle2 (Qiu et al., 2017) , we found a continuous progression from growing to senescence, with days 2 and 4 cells as intermediates and two distinct senescent populations ( Figure 1C ), suggesting two facultative, alternative endpoints. To determine whether RasV12 activation led to the split into two senescence populations ( Figure 1C ), we overlaid RasV12 expression onto the monocle plot (Figures 1B and  1C; Figures S1F and S1G; Table S3 ). RasV12-expressing cells ( Figure 1C ; Ras+, round symbols) progressed to both senescence endpoints with a 21:4 skew toward the cluster designated OIS. Fibroblasts without detectable RasV12 expression uniformly progressed to the cluster tentatively designated secondary senescence, suggesting it as the obligate endpoint (cross symbols, RasÀ; Figure 1C ; Fisher's exact test, 1.64 3 10 À6 ).
Our inability to detect RasV12 in a subset of senescent cells suggests that senescence was induced as a secondary event. We verified HRAS as one of the top predicted upstream regulators for the senescence top population (p = 3.1 3 10 À34 ) by using Ingenuity pathway analysis (IPA, QIAGEN; Figure S1H ). We confirmed a senescence phenotype for both populations by upregulation of key senescence genes ( Figure 1D ) cyclin-dependent kinase 1a (CDKN1A) and cyclin-dependent kinase inhibitor 2b (CDKN2B) and SASP factors interleukin 8 (IL8), interleukin 6 (IL6), and interleukin 1B (IL1B) (p < 0.05 for all genes; Figure 1D ). To verify two major senescence populations transcriptomewide, we used a consensus clustering approach, SC3 (Kiselev et al., 2017) , with the number of clusters determined by silhouette plot (Rousseeuw, 1987) ( Figure S1I ). SC3 detected two senescence clusters largely overlapping with the subpopulations obtained by Monocle2 (cluster 1 16/21 or 76% RasV12+ cells, cluster 4 11/15 or 73% RasV12À cells), supporting the notion that the split into two senescence populations is based on the absence or presence of RasV12 ( Figure 1E ). To verify that populations observed are due to primary OIS and secondary senescence, we co-cultured ER:IMR90 with IMR90:GFP fibroblasts (10:1), where secondary senescence is induced in IMR90:GFPpositive cells (Acosta et al., 2013) . We generated scRNA-seq data before and 7 days after RasV12 activation by using the 103 Genomics Chromium ( Figure 1F ). Senescence was confirmed on sorted populations by qPCR ( Figure S1J ) and SA-Beta Gal staining for primary and secondary senescent cells ( Figure S1K ). Cells were annotated based on GFP, RasV12 expression, and the G > T mutation of Ras gene ( Figure 1G ). We identified three distinct clusters using Seurat and Sparcl (Butler et al., 2018; Witten and Tibshirani, 2010) , namely growing (blue dots), secondary senescence (GFP positive, black dots) and OIS (RasV12 positive, red dots), with significant enrichment for the OIS and secondary senescence populations (chi-square test, p = 4.1 3 10 À14 ; Figure 1H ). The secondary senescence cluster also contained a minor population of RasV12-expressing cells. This mirrors our earlier findings, confirming two facultative senescence endpoints for primary RasV12 senescent cells, with GFP-positive secondary senescent cells showing a uniform distribution. Senescence genes were upregulated in both senescent clusters, including CDKN1A, CDKN2B, and IL8 ( Figure 1I ; Table S2 ) and longterm stable cell cycle arrest confirmed at 21 days post co-culture ( Figure S1L ). When overlaying transcriptomes of the time course and the co-culture experiments, a significant number of cells identified as OIS and secondary senescence (GFP and part of RasV12) clustered together ( Figure 1J ; chi-square test, p < 0.05). The co-clustering by senescent signatures was achieved despite the data being generated by 103 or Smart-Seq2. In summary, we identified two major transcriptional endpoints in primary OIS, whereas secondary senescent cells were uniformly assigned. Paracrine senescence is thought to be the main effector mechanism for secondary, cell extrinsic senescence induction (Acosta et al., 2013; Kuilman et al., 2008) . To test if the secondary senescence cluster is explained by a paracrine signature, we overlaid bulk RNA-seq data (Acosta et al., 2013) . Although we found a significant overlap with paracrine genes (hypergeometric test: paracrine/OIS and time course secondary senescence/OIS (RasÀ/Ras+) p < 0.001; paracrine/OIS and 103 secondary senescence/OIS p < 0.001, 103 secondary senescence/OIS and time course secondary senescence/OIS (RasÀ/Ras+) p < 0.001; Figure 1K ; Table S4 ), a large fraction of genes shared between our two single cell experiments remained unexplained, suggesting the involvement of additional pathways in secondary senescence.
The Transcriptome of Secondary and a Subset of Primary Senescent Cells Is Characterized by Notch Because the secondary senescence clusters were only partially characterized by a paracrine senescence signature, we explored consistent differences between the secondary senescence and the primary OIS clusters. We assessed the most differentially expressed genes and detected fibrillar collagens (collagen 1A1, 3A1, and 5A2; Figure 2A ). Downregulation of fibrillar collagens is consistently observed in senescence (Hoare et al., 2016) , but they failed to downregulate in the secondary senescence cluster (Table S2; Figure 2A) . A similar failure to downregulate collagens was reported in a specialized primary senescence phenotype, induced by ectopic, temporal activation of Notch (Hoare et al., 2016) . The same report suggested that the secretome in RasV12-induced senescence was regulated by CCAAT-enhancer-binding protein beta (CEBPB), with Notchinduced senescence relying on transforming growth factor beta (TGFB) ( Figure 2B ) (Hoare et al., 2016) . Several lines of evidence identify a notch-induced senescence (NIS) signature in the secondary senescence cluster. First, IPA pathway analysis Related to Figure S1 and Tables S1-S4 . identifies TGFB1 as exclusively activated in the secondary senescence clusters compared to growing or the primary OIS ( Figure 2C ). In contrast, RELA and IL1B pathways, regulators of the CEBPB transcriptome, were differentially activated in primary OIS clusters ( Figure 2C ). Consistent with our RasV12 annotation, HRAS was exclusively activated in primary OIS ( Figure 2C ; Figure S2A ). Second, we profiled candidate genes involved in Notch signaling and TGFB activation. When plotting TGFBinduced transcript 1, (TGFB1I1) with Notch-target connective tissue growth factor (CTGF) and CEBPB, we identified a significant (p < 0.05) upregulation of CTGF and TGFB1I1 genes in the secondary senescence cluster with a simultaneous downregulation of CEBPB, significant on the protein but not mRNA level (Figures 2D and 2E ; p = 0.016), resembling the TGFB and CEBPB bias in NIS. This bias was confirmed by qPCR ( Figure 2D ; TGFB1 p = 0.02, TGFBI p = 0.05).
Third, we applied an unbiased genome-wide analysis. We calculated the enrichment of NIS and Ras-induced senescence (RIS) signatures in the primary OIS and secondary senescence transcriptomes by using gene set enrichment analysis (GSEA) (Subramanian et al., 2005) on ranked transcriptome differences between NIS and RIS ( Figure 2F ). Secondary senescence signatures from the time course and co-culture experiments were highly enriched in NIS (normalized enrichment score [NES] = 2.61, false discovery rate [FDR] < 0.005 for time course; NES = 2.89, FDR < 0.005 for co-culture experiments; Figure 2F ). Primary OIS transcriptomes showed an enrichment for RIS (Figure S2B) . Finally, we interrogated the extent of NIS in secondary senescence by comparing the most differentially regulated genes (adjusted p < 0.05) between RIS and NIS. We found a significant enrichment of NIS genes in our secondary senescence transcriptome in the time course and co-culture experiments, with primary OIS signature being enriched for RIS (Figures 2F and 2G; Figures S2B and S2C) . In summary, our data identify a pronounced NIS signature in secondary senescence and in a subset of primary senescent cells as an alternative endpoint to OIS.
NIS Is a Secondary Senescence Effector Mechanism during OIS
We next established Notch signaling as an effector mechanism in secondary senescence. We generated IMR90 fibroblasts with compromised Notch signaling by introducing a dominantnegative form of mastermind-like protein 1 fused to mVenus (mVenus:dnMAML1) or empty vector (mVenus:EV) control and co-cultured with ER:Ras IMR90 cells in the presence of tamoxifen ( Figure 3A) . At day 7 co-culture, mVenus:dnMAML1 compared to mVenus:EV cells exhibited lower expression of extracellular matrix gene COL3A1 (p = 0.02) and Notch target CTGF (p = 0.056; Figure S3A ) as measured by qPCR, confirming impaired Notch signaling. Several lines of evidence show causal involvement of Notch signaling in secondary senescence. First, we scored mVenus (YFP) signal between mVenus:dnMAML1 and mVenus:EV cells at day 0 (growing) and day 7 co-culture with ER:Ras. At day 7, we observed significantly more mVenus:dnMAML1 compared to mVenus:EV cells (p = 0.01), suggesting that primary OIS cells have less secondary senescence effect on neighboring cells when harboring perturbed Notch signaling ( Figure S3B ). No significant difference in mVenus-positive cells was observed in growing mVenus:EV compared to mVenus:dnMAML1 cells (p = 0.38), showing that the dnMAML1 itself does not affect cell numbers (Figure S3B) . Second, we scored EdU incorporation between mVenus:dnMAML1 and mVenus:EV cells at days 0 and 7 (Figure 3B) . At day 7, we observed significantly more EdU incorporation in mVenus:dnMAML1 compared to mVenus:EV cells (p = 0.01), with day 7 mVenus:dnMAML1 cells showing similarly high levels of EdU incorporation as growing mVenus:dnMAML1 and growing mVenus negative ER:Ras conditions (p = 0.997 and p = 0.08), suggesting that the induction of secondary senescence was abolished due to Notch perturbation ( Figure 3B ). As expected, ER:Ras cells showed low levels of EdU incorporation at day 7 tamoxifen (p = 0.01 for ER:Ras/mVenus:dnMAML1 co-culture and p = 0.0005 for ER:Ras/mVenus:EV co-culture; Figure 3B ).
Third, we investigated SAHF in primary OIS and secondary senescence. Primary OIS cells displayed SAHF as expected (p = 4.437 3 10 À6 ; Figure S3C ). Secondary senescent cells (mVenus:EV) did not show significant SAHF formation when compared to OIS (p = 0.32; Figure S3C ). This is consistent with published data where impaired Notch signaling partially suppresses SAHF formation in primary senescence (Parry et al., 2018) . In summary, we show that Notch signaling mediates secondary senescence in vitro. Figure S2 and Table S4 . To establish transcriptional differences between secondary senescence with and without Notch signaling, we generated scRNA-seq data from IMR90 mVenus:EV and mVenus:dn-MAML1 co-cultures with ER:Ras IMR90 at day 7 tamoxifen. To integrate this dataset with our previous secondary senescence transcriptomes ( Figure 1H ), we projected the mVenus:EV and mVenus:dnMAML1 using Scmap (Kiselev et al., 2018) . Scmap clearly matches all primary senescent cells containing RasV12 to the OIS population ( Figure 3C ) and identifies significantly more secondary senescence cells in mVenus:EV compared to mVenus:dnMaml1 ( Figure 3C ; 37% versus 24%, chi-square test, p = 0.00062), confirming a role of Notch in secondary senescence. To explore transcriptomic differences between secondary senescence, we plotted all cells using Seurat, which separated mVenus:EV and mVenus:dnMAML1 into distinct secondary senescence clusters ( Figure 3D ). We confirmed differences in the activation of Notch pathway between mVenus:EV and mVenus:dnMaml1 by GSEA analysis ( Figure 3E ; NES = À1.35) and on the gene level for fibrillar collagens ( Figure 3F ; p < 0.05). Notch signaling blunts the cytokine response in senescence as SASP factors ( Figure 3G ; NES = 1.1) and the interferongamma response ( Figure S3D ; NES = 1.48) are differentially regulated between mVenus:EV and mVenus:dnMaml1, as judged by GSEA. Importantly, E2F targets, whose downregulation is one of the hallmarks of senescence, are upregulated in mVenus:dnMaml1 cells compared to mVenus:EV ( Figure 3H ; p = not significant [n.s.]) (Narita et al., 2003) , which offers an explanation for the strong phenotype differences we observed between the two conditions (see Figure 3B) .
Notch induces senescence in a juxtacrine manner through cell-to-cell contact. We performed transwell experiments to verify the effect of cell-to-cell contact on the secondary senescence transcriptome. We co-cultured ER:Ras cells with GFP cells (GFP contact; Figure 3I ) and GFP cells on their own in the transwell of the same well (GFP no contact). In this setting, GFP no contact cells shared media with ER:Ras cells, where cytokines can be transferred but no cell-to-cell contact is possible. We performed bulk RNA-seq of GFP contact and no contact cells 7 days after tamoxifen induction and confirmed enhanced expression of previously observed marker genes for NIS secondary senescence in GFP contact cells ( Figure 3J ). In addition, GSEA confirmed enrichment of Notch (NES = 1.59, FDR q = 0.019) and TGFB (NES = 1.87, FDR q = 0.0016) signaling (Figures 3K and S3E) in GFP contact cells. Pathway analysis confirmed significant upregulation of previously described senescence pathways, such as ''Senescence and Autophagy in Cancer'' and ''Matrix Metalloproteases'' in GFP contact compared to GFP no contact cells ( Figure 3L ). Equally, GSEA showed repression of E2F target genes in GFP contact compared to GFP no contact fibroblasts ( Figure 3M ) except for E2F7, which is known to be upregulated in senescence ( Figure 3J ) (Aksoy et al., 2012) . GSEA analysis suggests that the global differences between GFP contact and no contact cells resemble the differences between mVenus:EV and mVenus:dnMaml1 secondary senescence ( Figure S3F) .
OIS induction is a multi-step process with an early proliferative phase at days 1-3, followed by a phenotype transition phase at days 3-5, and established senescence from day 7 after RasV12 expression (Young et al., 2009) . To compare the impact of the different phases of primary OIS onto secondary senescence, we co-cultured mVenus:EV or mVenus:dnMAML1 cells repeatedly with ER:Ras cells at days 3-6 or at days 7-10 after RasV12 induction ( Figure S3G ). As expected, ER:Ras cells showed low levels of EdU incorporation in mVenus:dnMAML1 (day 7, p = 0.01) or mVenus:EV co-culture (day 7, p < 0.001) (Figures S3H and S3I) as a result of primary OIS. Co-culturing mVenus:EV with ER:Ras cells in the phenotype transition phase (days 3-5 after RasV12 induction) lead to a significant reduction in EdU when compared to uninduced co-cultures (p < 0.001; Figure S3H) , suggesting that secondary senescence was induced by transition-phase primary OIS cells. The transition-phase effect is Notch-dependent because it cannot be induced in mVenus:dnMAML1 cells (p = 0.12; Figure S3I ). In contrast, by co-culturing mVenus:EV cells with primary OIS cells in established senescence phase (days 7-10 after RasV12 induction), we were unable to detect a reduction in EdU incorporation in mVenus:EV cells compared to uninduced co-cultures (p = 0.59; Figure S3H ), mirroring results obtained in mVenus:dnMAML1 co-cultures (p = 0.99; Figure S3I ). From day 4 co-culture, we detected a significant upregulation of Notch1 on the cell surface of mVenus:EV (p = 0.041 day 4, p = 0.038 day 7; data not shown) and mVenus:dnMaml1 (p = 0.023 day 4, p = 0.046 day 7; data not shown) cells compared to growing, providing a pathway to NIS induction ( Figure S3J ). (M) GSEA pre-ranked analysis for enrichment of E2F targets in GFP no contact compared to GFP contact cells. Leading edge genes are indicated. Related to Figure S3 and Table S2 . 
(legend continued on next page)
These results highlight a need for ER:Ras fibroblasts to be in phenotype transition phase to mediate secondary senescence by Notch1. Overall, our data identify Notch as a key mediator of secondary senescence.
Secondary Senescent Hepatocytes Are Characterized by NIS Signature
To test the involvement of NIS in vivo, we used a model where primary senescence is induced in a subpopulation of hepatocytes following Mdm2 deletion (Bird et al., 2018 (Bird et al., 2018) (Figure 4A ). In this model, the presence of p53 induction through Mdm2 deletion with medium levels of CDKN1A (non-senescence/primary p < 0.001) marks primary senescence induction (Bird et al., 2018) ( Figure 4B ; Figure S4A and S4B). Physiological levels of P53 and high levels of CDKN1A (CDKN1A expression secondary/primary p < 0.0001) marks secondary senescence in Mdm2 normal (Mdm2+) hepatocytes as described (Bird et al., 2018) (Figure 4B ). Based on these characteristics, cells can be readily distinguished by immunohistochemistry with 23% of primary and 10% of secondary senescence hepatocytes detected ( Figure S4A ). We have previously shown that both subpopulations of hepatocytes upregulate senescence markers (gH2AX, Il1A, SA-Beta Gal) and reduce BrdU incorporation (Bird et al., 2018) . To establish if primary and secondary senescence can be distinguished based on the transcriptome in vivo, we performed scRNA-seq on hepatocytes using Smart-Seq2 ( Figure 4A ). After filtering (Figure S4B and S4C ; Table S1), we retained 39 single cells from induced Mdm2-deleted mouse liver for downstream analysis. We distinguished Mdm2À cells from Mdm2+ hepatocytes by the absence of mapping reads over exon 5 and 6 of the Mdm2 gene ( Figure S4D ). We detected expression of Cdkn1a in both senescent populations consistently with the differences in CDKN1A protein levels detected by immunohistochemistry ( Figure 4B ), with lower (but not significant) Cdkn1a expression in Mdm2À compared to Mdm2+ hepatocytes ( Figure S4E ), enabling us to distinguish primary and secondary senescence. To verify a senescence phenotype in both Mdm2À and Mdm2+ hepatocyte populations, we conducted pathway analysis with upregulated pathways being enriched in p53 signaling, including CDKN1A, DNA damage response, and cytokine signaling ( Figure S4F ). We next asked if NIS plays a role in secondary senescence in vivo by analyzing our single-cell data by using three independent methods. Differentially expressed genes between Mdm2+ and Mdm2À cells were identified using single cell differential expression (SCDE) (Table S2) , and genes were ranked between Mdm2+/Mdm2À cells for downstream analysis. First, pathway analysis revealed enrichment in Notch signaling (ratio of enrichment [RE] , 7.07), Delta-Notch signaling (RE, 4.63), and TGFB (RE, 4.11) signaling pathways ( Figure 4C ). Second, GSEA revealed Notch signaling pathway (NES = 1.07) as one of the top 20 Kegg pathways enriched in Mdm2+/ Mdm2À ( Figure 4D ) with leading edge genes Maml1 and Jag2 detectable mainly in Mdm2+ cells (Fisher's exact test = 6.93 3 10 À7 ; Figure 4E ). Housekeeping and hepatocyte-specific genes were expressed to the same level in the majority of cells regardless of Mdm2 status ( Figure 4E ). Third, SCDE analysis confirmed the specific upregulation of Notch and TGFB targets Maml1 (adjusted Z score [aZ] = 0.4) and Rfng (aZ = 0.39) with effector protein Smad3 (aZ = 0.26) in Mdm2+ compared to Mdm2À hepatocytes ( Figure 4F ). To assess the proposed TGFB and CEBPB bias between primary and secondary senescence in vivo, we stained livers from uninduced and induced mice for CDKN1A and CEBPB by immunohistochemistry. Consistent with our in vitro data, we observed significantly higher CEBPB protein in primary (p < 0.0001; Figure 4G ) compared to secondary senescent hepatocytes. These lines of evidence show that secondary senescent hepatocytes are characterized by a NIS signature in vivo.
DISCUSSION
Cancer heterogeneity is an expanding field of research, with little knowledge about cellular heterogeneity in a pre-cancerous state. Are all cells reacting similarly to oncogene activation or does an oncogenic insult result in a heterogeneous population? Understanding heterogeneity in a pre-cancerous state will inform distinct propensities for transformation in subpopulations. Our study uncovers heterogeneity in primary OIS and secondary senescence transcriptomes following an oncogenic insult using single-cell approaches. Paracrine induction of senescence is thought to be the main mediator of secondary senescence in OIS (Acosta et al., 2013; Kuilman et al., 2008) . Our results challenge this canonical view implicating NIS as a synergistic driver of secondary senescence in vitro, in the most studied OIS background (RasV12) and in the liver in vivo.
Primary and secondary senescent cells are not thought of as functionally distinct endpoints. We provide strong evidence for differences between primary OIS and Notch-mediated juxtacrine Figure S4 and Tables S1 and S2. secondary senescence, as they display distinct gene expression profiles and potentially different transformation potential (Acosta et al., 2013; Hoare et al., 2016) . Some of our findings point to a functional diversification, for example, the blunted SASP response and the induction of fibrillar collagens in secondary senescence compared to OIS.
We identified two transcriptional endpoints for primary OIS, namely a Ras-driven and a NIS program. Notch signaling is mediated through cell-to-cell contact (juxtacrine), and Hoare et al. (2016) have shown that it can be a transient state toward primary senescence induction. Our data indicate cells carrying a composite transcriptional signature of paracrine and juxtacrine events as a facultative endpoint for cells with detectable Ras activation (primary). The transformation potential of these heterogeneous populations needs addressing.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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Kirschner, K., Chandra, T., Kiselev, V., Flores-Santa Cruz, D., Macaulay, I.C., Park, H.J., Li, J., Kent, D.G., Kumar, R., Pask, D.C., et al. (2017 Immunohistochemistry Mouse livers were harvested and partially stored in paraffin blocks following fixation in 10% formalin (in PBS) for 18 hours prior to embedding. Immunohistochemistry was performed as described (Bird et al., 2018) . Three mm thick paraffin sections were double stained for p53/CDKN1A and CDKN1A and CEBPB using the CDKN1A clone HUGO291H (a gift from Serrano lab, CNIO in Madrid), and either C/EBPB clone 1H7 (Abcam) or p53 clone 1C12 (Cell Signaling). Detection was performed with TSA-Cy3 (Perkin Elmer, NEL744B001KT, 1:50) and TSA-FITC (Perkin Elmer, NEL741B001KT, 1:50). Images were captured on a Zeiss 710 Upright Confocal Z6008 microscope. Stained slides were scanned using the Opera Phoenix High Content screening system (Perkin Elmer) scanner and analyzed using the Columbus software.
Transwell assay ER:Ras G12V -expressing cells were co-cultured with IMR90:GFP cells. The co-cultured cells were placed into the lower chamber of a transwell system (density 5x10 3 cells/well). Another pure population of IMR90:GFP cells were cultured in the upper chamber of the transwell system. All cells were maintained in 4-hydroxytamoxifen (Sigma) for 7 days. All experiments were performed in triplicate.
Flow cytometry
Flow cytometry was performed with three independent replicates as previously described (Kirschner et al., 2017) using 7-AAD (Biolegend), DAPI (Biolegend) and anti-Notch1-PE (R&D systems, FAB5317P, 1:20) . Analysis was performed on the BD FACSAria II (BD Biosciences, San Jose, CA) using the BD CellQuest PRO software (BD Biosciences, San Jose, CA). Flow data were analyzed with FlowJo v10 (Tree Star, Ashland, OR).
RNA extraction
RNA from three to four independent experiments was extracted using the RNeasy Mini Kit (QIAGEN). All RNA passed with a RIN of 9 or above as determined by Bioanalyser profiling. Ribosome depletion was performed prior to bulk RNA sequencing.
qPCR cDNA was generated as previously described using the Tetro cDNA synthesis kit (Bioline) (Kirschner et al., 2015) . qPCR was performed on a LightCycler 480 (Roche) using Sybr Green method as previously described (Kirschner et al., 2015) . Primer sequences are in Table S3 .
EdU incorporation and SA-Beta Gal staining EdU incorporation and SA-Beta gal staining was performed as previously described (Kirschner et al., 2015) . EdU incorporation was detected using the Click-iT EdU Alexa Fluor 555 imaging kit (ThermoScientific). For stable cell cycle arrest, cells were co-cultured for two weeks, separated by FACS according to GFP status and cultured as OIS and GFP cells for another week before pulsing them with EdU for 24 hours.
Immunofluorescence
Immunoflurorescence was performed as previously described (Kirschner et al., 2015) . Anti-C/EBPB clone E299 (Abcam) was used as 1:500 dilution.
Confocal microscopy and Image analysis BriteMac confocal microscope was used to visualize cells at 40x. Images were analyzed using ImageJ. Percentages of SAHF, YFP/GFP and EdU-positive cells were calculated by assessing 1600-2000 cells per experiment from three independent experiments.
Single cell data generation Smart-Seq2 was performed on sorted ER:IMR90 cells or hepatocytes as previously described (Kirschner et al., 2017) . Single cell data for all co-culture experiments were generated using the Chromium Single Cell 3 0 Chip Kit v2 (10xGenomics), following the manufacturer's instructions.
QUANTIFICATION AND STATISTICAL ANALYSIS

Bioinformatics analysis
Sequencing reads processing, alignment and quantification of time-course experiment Smart-Seq2 generated paired-end reads were quality trimmed using Trim galore (http://www.bioinformatics.babraham.ac.uk/ projects/trim_galore/) and aligned to the human reference genome, hg19, neomycin sequence from pLNCX2-ER-ras_neo, ERCC spike-in sequences and RasV12 using HISAT v2.0.1beta (Kim et al., 2015) . Cells with less than 200,000 hg19 aligned reads, and a ratio of ERCC RNA spike-in control aligned reads to total aligned reads greater than 0.5 were omitted. hg19 aligned reads were randomly downsampled to 200,000 reads. Genes were quantified using HTSeq-0.6.1 . Cells with more than 80,000 total gene counts and at least 500 genes with at least one count were used for downstream analysis. 224 IMR90 cells Notch and Ras-induced senescence data and GSEA analysis We used NIS and RIS RNA-seq data with accession number GSE72404. Reads were aligned to as described above. Differential gene expression analysis between NIS and RIS was performed using DESeq2 (Love et al., 2014) . The log2 fold change for each gene was used to rank the list of genes in GSEA Preranked analysis (Subramanian et al., 2005) . Differentially expressed (DE) genes between senescence top and bottom were identified using SCDE with a p value cutoff of 0.05. The DE genes defined the gene set in GSEA Preranked analysis. Sequencing reads alignment and quantification of transwell bulk RNA-sequencing data Reads were aligned to the human reference genome hg19 using HISAT v2.0.1beta (Kim et al., 2015) and those that mapped to annotated genes were quantified using HTSeq-0.6.1 . Differential gene expression was determined using DESeq2 v1.22.1 (Love et al., 2014) . Over-representation analysis was performed using WebGestalt and GSEA pre-ranked analysis was performed using the ranking of genes based on the log2FC between GFP contact and GFP no contact.
Statistical analysis
All t tests and one-way ANOVA for the in vitro data were performed in R. TukeyHSD was used as the post hoc test for one-way ANOVA. For the in vitro data, each experiment and measurement were obtained from three independent experiments unless otherwise specified in the figure legends. Barplots are represented as means with SEM. Statistical significance was set at p < 0.05. t test for the in vivo data was performed in R and the two-way ANOVA followed by Tukey's test for the in vivo data was performed using GraphPad Prism. All animal data were obtained from three biological replicates. Details of all statistical analysis can be found in associated figure legends. For qPCR analysis, Delta delta Ct method was used for quantification with error bars resulting from the delta Ct expression of three to four biological replicates. A two-sided t test was used to calculate p values.
DATA AND SOFTWARE AVAILABILITY
All scRNA-seq and bulk RNA-seq experiments are accessible through GEO accession number GEO: GSE115301. All imaging data are available as Mendeley dataset under https://doi.org/10.17632/y76pb7s8h3.1.
